• ECL Western Blotting Substrate: Workflow Guide

  2026-08-08

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for chemiluminescent Western blot assays. It is intended for HRP-mediated immunoblot imaging with film or CCD systems, not for fluorescent or radioisotopic detection workflows.

• ω-Agatoxin IVA and Cortical Excitotoxicity

  2026-08-07

  Lustig, Ahern, and Greenberg tested whether selective P/Q-type calcium-channel blockade could protect cortical neurons from excitotoxic injury. Their negative result shows that inhibiting toxin-sensitive calcium channels or presynaptic glutamate release is not, by itself, sufficient to prevent acute neuronal damage in this culture model.

• AICAR and Mitophagy: Precision Tools for Metabolic Stress Re

  2026-08-07

  Explore how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) enables targeted dissection of AMPK-dependent mitophagy for metabolic disease research. This article uniquely bridges recent mechanistic insights to practical assay optimization.

• 10 mM dNTP Mixture: Precision DNA Synthesis for Modern Workf

  2026-08-06

  APExBIO’s 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture stands as a benchmark DNA synthesis reagent, enabling high-fidelity PCR, qPCR, and sequencing with exceptional reproducibility. Its equimolar, pH-stabilized formulation simplifies complex experimental designs and empowers cutting-edge nucleic acid delivery research.

• Metformin Hydrochloride: Protocol Innovations for Fibrosis &

  2026-08-06

  Metformin Hydrochloride (Metformin HCl) is redefining fibrosis and metabolic pathway research by enabling precise AMPK pathway modulation and inhibition of hepatic gluconeogenesis. This guide bridges cutting-edge findings with actionable protocols, troubleshooting insights, and comparative applications for advanced bench workflows.

• Berberrubine's Role in NAFLD: Glucose, Lipid, and Microbiota

  2026-08-05

  Yang et al. demonstrate that berberrubine, a principal metabolite of berberine, alleviates non-alcoholic fatty liver disease (NAFLD) by modulating glucose and lipid metabolism and restoring gut microbiota balance. This research provides mechanistic insights with translational potential for metabolic liver disease intervention.

• BKT140 (BL-8040): Transforming CXCR4-Driven Cancer Research

  2026-08-05

  Discover how BKT140 (BL-8040), a potent CXCR4 antagonist, is reshaping the landscape of tumor progression and stem cell mobilization studies. This article delivers in-depth insight into its mechanism, assay optimization, and evolving role in oncology research.

• ω-Agatoxin IVA Suppresses Seizures and Modulates BDNF/Caspas

  2026-08-04

  This study demonstrates that the P/Q-type calcium channel blocker ω-Agatoxin IVA significantly delays seizure onset and modulates neuroprotective markers in a rat epilepsy model. The findings highlight a mechanistically distinct approach to anticonvulsant and neuroprotective research, with translational implications for synaptic transmission and neuronal survival.

• DeferoxamineB in Cancer Research: Protocols, Workflows, and

  2026-08-04

  Deferoxamine (DeferoxamineB) enables precision iron chelation and the fine-tuning of regulated cell death in experimental oncology, with applications spanning ferroptosis, autophagy, and apoptosis assays. This guide distills the latest workflow enhancements, troubleshooting strategies, and emerging cross-domain insights, helping researchers maximize both assay reliability and translational impact.

• 3-Deazaneplanocin (DZNep): Reliable Epigenetic Modulator for

  2026-08-03

  This article offers scenario-driven, evidence-based guidance for using 3-Deazaneplanocin (DZNep, SKU A1905) in cell-based assays targeting oncology and metabolic disease models. With a focus on protocol optimization, reproducibility, and vendor reliability, it empowers researchers to maximize data quality and workflow efficiency.

• Silybin A in Silymarin: Translational Leverage for Liver Dis

  2026-08-03

  This thought-leadership article explores the mechanistic and strategic landscape of Silybin A—a principal flavonolignan in Silymarin—focusing on its antioxidant, anti-inflammatory, and hepatoprotective mechanisms relevant to advanced liver disease and metabolic research. It synthesizes biochemical insight, protocol guidance, and translational strategy, offering a roadmap for researchers seeking rigor and impact in hepatoprotection and metabolic modulation studies.

• M344 Histone Deacetylase Inhibitor: Protocols and Innovation

  2026-08-02

  M344 stands out as a potent, cell-permeable histone deacetylase inhibitor, enabling advanced cancer and HIV latency research with unmatched precision. This article delivers actionable protocols, experimental insights, and troubleshooting strategies that maximize the value of M344 in epigenetic and oncology workflows.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-08-01

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent optimized for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is strictly intended for in vitro laboratory use and is not recommended for in vivo or clinical research due to the absence of supporting data.

• CKI 7 dihydrochloride: Advanced Insights for CK1 Pathway Res

  2026-07-31

  Explore how CKI 7 dihydrochloride, a selective Casein kinase 1 inhibitor, enables deeper mechanistic studies in Wnt signaling, circadian rhythm regulation, and cancer biology. This article delivers unique assay design guidance and translational insight not found in existing resources.

• ATG4B Nuclear Translocation Links Energy Deficiency to AML P

  2026-07-31

  This study uncovers a direct molecular mechanism by which cellular energy deficiency impairs DNA repair in acute myeloid leukemia (AML) via ATG4B nuclear translocation and inhibition of PRMT1-mediated MRE11 methylation. The findings highlight a new therapeutic target for mitigating genomic instability and leukemic progression, with implications for metabolic-genomic crosstalk in cancer.

8482 records 8/566 page Previous Next First page 上5页 678910 下5页 Last page